Abstract
Nodular glomerulosclerosis, typically diagnosed in patients with diabetes mellitus, has been reported in native kidneys of pre-diabetic patients but similar cases in kidney transplant recipients are lacking. We describe a case of nodular glomerulosclerosis in a kidney transplant recipient who had not been found to be diabetic despite regular screening and discuss the implications for the pathogenesis and diagnosis of nodular glomerulosclerosis and screening of post-transplant diabetes mellitus.
Similar content being viewed by others
Abbreviations
- AGE:
-
Advanced glycation end product
- CKD:
-
Chronic kidney disease
- CNI:
-
Calcineurin inhibitors
- DM:
-
Diabetes mellitus
- DN:
-
Diabetic nephropathy
- EM:
-
Electron microscopy
- HbA1c:
-
Glycated hemoglobin
- HLA:
-
Human leukocyte antigen
- KTR:
-
Kidney transplant recipient
- IFG:
-
Impaired fasting glucose
- IGT:
-
Impaired glucose tolerance
- IMF:
-
Immunofluorescence
- OGTT:
-
Oral glucose tolerance test
- PTDM:
-
Post-transplant diabetes mellitus
References
American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes—2020. Diabetes Care. 2019;42(Suppl 1):S13–28. https://doi.org/10.2337/dc19-S002.
Sharif A, Ravindran VMR. Insulin resistance indexes in renal transplant recipients maintained on tacrolimus immunosuppression. Transplantation. 2010;89(3):327–33. https://doi.org/10.1097/TP.0b013e3181bbf2c4.
Venkataraman K, Khoo CMLM. New measure of insulin sensitivity predicts cardiovascular disease better than HOMA estimated insulin resistance. PLoS ONE. 2013;8(9):e74410. https://doi.org/10.1371/journal.pone.0074410.
Jia T, Huang XQA. Validation of insulin sensitivity surrogate indices and prediction of clinical outcomes in individuals with and without impaired renal function. Kidney Int. 2014;86(2):383–91. https://doi.org/10.1038/ki.2014.1.
Paul Kimmelstiel CW. Intercapillary lesions in the glomeruli of the kidney. Am J Pathol. 1936;12(1):83–98.
K O Alsaad AMH. Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update. J Clin Pathol. 2007;60(1):18–26. https://doi.org/10.1136/jcp.2005.035592.
Baradhi KM, Gary Abuelo JSI. The case: diabetic nephropathy in a nondiabetic smoker? Kidney Int. 2012;82(10):1141–2. https://doi.org/10.1038/ki.2012.333.
Markowitz GS, Lin J, Valeri AM, Avila C, Nasr SHDVD. Idiopathic nodular glomerulosclerosis is a distinct clinicopathologic entity linked to hypertension and smoking. Hum Pathol. 2001;33(8):826–35. https://doi.org/10.1053/hupa.2002.126189.
Qian Y, Feldman E, Pennathur S, Matthias Kretzler FCBI. From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy. Diabetes. 2008;57(6):1439–45. https://doi.org/10.2337/db08-0061.
Mise K, Ueno THJ. Nodular lesions in diabetic nephropathy: collagen staining and renal prognosis. Diabetes Res Clin Pr. 2017;127:187–97. https://doi.org/10.1016/j.diabres.2017.03.006.
Wada T, Shimizu MYH. Nodular lesions and mesangiolysis in diabetic nephropathy. Clin Exp Nephrol. 2013;17(1):3–9. https://doi.org/10.1007/s10157-012-0711-6.
Jonatan Barrera-Chimal FJ. Pathophysiologic mechanisms in diabetic kidney disease: a focus on current and future therapeutic targets. Diabetes Obes Metab. 2020;22(Suppl 1):16–31. https://doi.org/10.1111/dom.13969.
Nyumura I, Honda K, Babazono T, et al. Recurrence of diabetic kidney disease in a type 1 diabetic patient after kidney transplantation. Nephrol (Carlton). 2015;20(Suppl 2):90–2. https://doi.org/10.1111/nep.12454.
Rodriguez Cubillo B, Rodriguez B, Calvo M, de la Manzanara V, Bautista J, Perez-Flores I, Calvo N, Moreno A, Shabaka A, Delgado JS-FA. Risk factors of recurrence of diabetic nephropathy in renal transplants. Transpl Proc. 2016;48(9):2956–8. https://doi.org/10.1016/j.transproceed.2016.07.045.
Coemans M, Van Loon E, Lerut E, Gillard P, Sprangers B, Senev A, Emonds M-P, Van Keer J, Callemeyn J, Daniëls L, Sichien J, Verbeke G, Kuypers D, Chantal Mathieu MN. Occurrence of diabetic nephropathy after renal transplantation despite intensive glycemic control: an observational cohort study. Diabetes Care. 2019;42(4):625–34. https://doi.org/10.2337/dc18-1936.
Nishihama K, Nakai T, Kanai K, Sugiyama T. A Case of “Hidden” Diabetic nephropathy diagnosed by a combination of renal biopsy findings and continuous glucose monitoring system. CEN Case Rep. 2015;4(1):101–5. https://doi.org/10.1007/s13730-014-0150-1.
Bhatt AP, Gupta A, Vibha D, Sharma A, Mahajan S. Florid diabetic complications in impaired glucose tolerance. Saudi J Kidney Dis Transpl. 2013;24(1):86–8.
Kinoshita C, Inoue Y. A case of idiopathic nodular glomerulosclerosis with fibrin caps. Clin Exp Nephrol. 2011;15(6):937–41. https://doi.org/10.1007/s10157-011-0513-2.
Sanai T, Okuda S, Yoshimitsu T, et al. Nodular Glomerulosclerosis in patients without any manifestation of diabetes mellitus. Nephrol. 2007;12(1):69–73. https://doi.org/10.1111/j.1440-1797.2006.00743.x.
Chang CS, Yang CHC AH. Nodular glomerulosclerosis mimicking diabetic nephropathy without overt diabetes mellitus. Clin Nephrol. 2005;64(4):300–4.
Altiparmak MR, Pamuk ON, Pamuk GE, Apaydin GO S. Diffuse diabetic glomerulosclerosis in a patient with impaired glucose tolerance: report on a patient who later develops diabetes mellitus. Neth J Med. 2002;60(6):260–2.
Karalliedde JGL. Diabetes mellitus, a complex and heterogeneous disease, and the role of insulin resistance as a determinant of diabetic kidney disease. Nephrol Dial Transpl. 2016;31(2):206–13. https://doi.org/10.1093/ndt/gfu405.
Sharif ACS. Post-transplantation diabetes-state of the art. Lancet Diabetes Endocrinol. 2016;4(4):337–49. https://doi.org/10.1016/S2213-8587(15)00387-3.
Nasr SHDVD. Nodular glomerulosclerosis in the nondiabetic smoker. J Am Soc Nephrol. 2007;18(7):2032–6. https://doi.org/10.1681/ASN.2006121328.
Nakamura N, Taguchi KMY. AGEs-RAGE overexpression in a patient with smoking-related idiopathic nodular glomerulosclerosis. CEN Case Rep. 2018;7(1):48–54. https://doi.org/10.1007/s13730-017-0290-1.
Whaley-Connell A, Sowers JR. Insulin resistance in kidney disease: is there a distinct role separate from that of diabetes or obesity? Cardiorenal Med. 2018;8(1):41–9. https://doi.org/10.1159/000479801.
Wu J, Yu S, Tejwani V, Mao M. Idiopathic nodular glomerulosclerosis in Chinese patients: a clinicopathologic study of 20 cases. Clin Exp Nephrol. 2014;18(6):865–75. https://doi.org/10.1007/s10157-013-0929-y.
Choung HG, Bomback ASSM. The spectrum of kidney biopsy findings in patients with morbid obesity. Kidney Int. 2019;95(3):647–54. https://doi.org/10.1016/j.kint.2018.11.026.
Shivaswamy V, Boerner B, Larsen J. Post-transplant diabetes mellitus: causes, treatment, and impact on outcomes. Endocr Rev. 2016;37(1):37–61. https://doi.org/10.1210/er.2015-1084.
Naesens M, Kuypers DRSM. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol. 2009;4(2):481–508. https://doi.org/10.2215/CJN.04800908.
Sharif A, Hecking M, de Vries APJ, Porrini E, Hornum M, Rasoul-Rockenschaub S, Berlakovich G, Krebs M, Kautzky-Willer A, Schernthaner G, Marchetti P, Pacini G, Ojo A, Takahara S, Larsen JL, Budde K, Eller K, Pascual J, Jardine A, Bakker SJL, Vald MDS TG. Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions. Am J Transpl. 2004;14(9):1992–2000. https://doi.org/10.1111/ajt.12850.
Valderhaug TG, Jenssen T, Hartmann A, Midtvedt K, Holdaas H. Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation. Transplantation. 2009;88(3):429–34. https://doi.org/10.1097/TP.0b013e3181af1f53.
Bergrem HA, Valderhaug TGHA. Undiagnosed diabetes in kidney transplant candidates: a case-finding strategy. Clin J Am Soc Nephrol. 2010;5(4):616–22. https://doi.org/10.2215/CJN.07501009.
Jung M, Warren BGM. Performance of non-traditional hyperglycemia biomarkers by chronic kidney disease status in older adults with diabetes: results from the atherosclerosis risk in communities study. J Diabetes. 2018;10(4):276–85. https://doi.org/10.1111/1753-0407.12618.
Galindo RJ, Beck RW, Scioscia MF, Umpierrez GETK. Glycemic monitoring and management in advanced chronic kidney disease. Endocr Rev. 2020;41(5):bnaa017. https://doi.org/10.1210/endrev/bnaa017.
Funding
The authors confirm that the paper has not been published or submitted for publication elsewhere.
Author information
Authors and Affiliations
Contributions
All authors participated in the care of the patient and the writing of the paper.
Corresponding author
Ethics declarations
Conflict of interest
The authors have declared that no conflict of interest exists.
Ethics approval
Ethics approval for case reports is waived by the SingHealth Centralised Institutional Review Board.
Informed consent
Informed consent was obtained from the patient included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Liew, Z.H., Tan, P.H., Foo, M. et al. Nodular glomerulosclerosis in a kidney transplant recipient with impaired glucose tolerance: diabetic or idiopathic? A case report and literature review. CEN Case Rep 10, 273–280 (2021). https://doi.org/10.1007/s13730-020-00546-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13730-020-00546-x